𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas

✍ Scribed by Fabio M. Iwamoto; Andreas F. Hottinger; Sasan Karimi; Elyn Riedel; Jocelynn Dantis; Maryam Jahdi; Katherine S. Panageas; Andrew B. Lassman; Lauren E. Abrey; Martin Fleisher; Lisa M. DeAngelis; Eric C. Holland; Adília Hormigo

Publisher
Springer US
Year
2011
Tongue
English
Weight
174 KB
Volume
105
Category
Article
ISSN
0167-594X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Serum matrix metalloproteinase-9 in head
Serum matrix metalloproteinase-9 in head and neck squamous cell carcinomais a prognostic marker
✍ Henni Ruokolainen; Paavo Pääkkö; Taina Turpeenniemi-Hujanen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 239 KB 👁 1 views

## Abstract The aim of this study was to determine whether serum matrix metalloproteinase‐9 (MMP‐9) could predict cause‐specific and relapse‐free survival in patients with squamous cell carcinoma of head and neck. Furthermore, this study was designed to investigate whether there is an association b

Serum samples should not be used to asse
Serum samples should not be used to assess circulating matrix metalloproteinase-9 levels as a prognostic marker of disease
✍ Jose E. Tanus-Santos; Raquel F. Gerlach 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 36 KB

Ruokolainen et al. 1 have suggested recently that pretreatment serum matrix metalloproteinase (MMP)-9 levels could be of prognostic value in patients with head and neck squamous cell carcinoma. In addition, they have found that patients with high serum levels of MMP-9 had a 2-fold risk of dying comp